FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to gynaecology, and can be used for diagnosing endometriosis. Samples of patient’s menstrual blood are obtained, lipid extract of dry drops of menstrual blood is prepared, lipid profile of dry menstrual blood spots is obtained by high-performance liquid chromatography with mass spectrometry (HPLC-MS). Based on lipids PE P-16:0/18:1 and PE P-18:0/20:4, calculated is a response variable y':
where IPE P-16:0/18:1 _ area of peaks of lipid marker of plasmenyl-phosphatyl ethanolamine PE P-16:0/18:1 on a chromatogram of a sample of a lipid extract of a dry spot of menstrual blood of a patient, standard units; IPE P-18:0/20:4 _ area of peaks of the lipid marker of plasmenyl-phosphatyl ethanolamine PE P-18:0/20:4 on a chromatogram of a sample of a lipid extract of a dry spot of menstrual blood of a patient, standard units. At value y' from 0.68 to 1, endometriosis is diagnosed in the patient. At value y' from 0 to 0.68, the absence of endometriosis is diagnosed in the patient.
EFFECT: method enables early non-invasive diagnosis of endometriosis of various severity by analysing the lipid profile of dry drops of menstrual blood by HPLC-MS as a result of applying a classifying model built on the basis of a logistic regression method for calculating a response variable (y'): taking into account levels of 2 lipids: PE P-16:0/18:1 and PE P-18:0/20:4.
1 cl, 7 dwg, 4 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF DIAGNOSING STAGES I-II OF HIGH-GRADE SEROUS OVARIAN CANCER USING THE LIPID PROFILE OF BLOOD SERUM | 2022 |
|
RU2807396C1 |
METHOD OF PROCESSING CHROMATO-MASS-SPECTROMETRIC DATA TO INCREASE THE EFFICIENCY OF SEARCH FOR DIAGNOSTIC MARKERS IN CLINICAL STUDIES | 2021 |
|
RU2803128C2 |
METHOD FOR ASSESSING ENDOMETRIAL RECEPTIVENESS IN ENDOMETRIOSIS-ASSOCIATED INFERTILITY | 2020 |
|
RU2724381C1 |
METHOD FOR DIFFERENTIATION OF ENDOMETRIOSIS CENTERS OF DIFFERENT LOCALIZATION BY DIRECT MASS SPECTROMETRY | 2019 |
|
RU2737224C1 |
METHOD FOR ASSESSMENT OF ENDOMETRIAL IMPLANTATION CONSISTENCY IN PROLIFERATIVE-INFLAMMATORY DISORDERS IN ENDOMETRIUM IN ENDOMETRIOSIS ASSOCIATED WITH ENDOMETRIAL FACTOR OF INFERTILITY | 2020 |
|
RU2724384C1 |
METHOD FOR DIAGNOSING EXTERNAL GENITAL ENDOMETRIOSIS | 2021 |
|
RU2761539C1 |
METHOD OF EARLY GENETIC DIAGNOSTICS OF RISK FOR DEVELOPING GENITAL ENDOMETRIOSIS | 2017 |
|
RU2676693C1 |
METHOD FOR DIAGNOSTICS OF INITIAL FORMS OF EXTERNAL GENITAL ENDOMETRIOSIS | 2022 |
|
RU2793841C1 |
METHOD FOR PREDICTION OF EXTERNAL GENITAL ENDOMETRIOSIS IN PATIENTS WITH TYPE 1 DIABETES MELLITUS USING NOMOGRAMS | 2023 |
|
RU2814561C1 |
METHOD FOR PREDICTING THE RISK OF DEVELOPING DEEP INFILTRATIVE ENDOMETRIOSIS IN WOMEN OF REPRODUCTIVE AGE | 2022 |
|
RU2775544C1 |
Authors
Dates
2024-10-30—Published
2024-03-07—Filed